Author(s): Deepak Kardile, Mrunal Shirsat

Email(s): kardiledeepak@gmail.com

DOI: 10.5958/0974-360X.2021.00082.2   

Address: Deepak Kardile*, Mrunal Shirsat
Department of Pharmaceutical Sciences, Madhav University, Pindwara - 307026, (Rajasthan) India.
*Corresponding Author

Published In:   Volume - 14,      Issue - 1,     Year - 2021


ABSTRACT:
In this present investigation to studies of mercaptobenzimidazole-clubbed chalcone derivatives was efficiently synthesized, which is further characterized with the help of thin layer chromatography, spectroscopy techniques such as FTIR and 1HNMR. The newly synthesized derivatives were examined against in vitro antimicrobial and antitubercular activities. The result revealed that the titled compounds an average antibacterial activity against gram-positive Bacillus subtilis, gram-negative Escherichia coli as compared to standard ciprofloxacin. Compounds DPK4B2d2, DPK4B2d3, DPK4B2d4 and DPK4B2d6 shown potent antifungal activity against Aspergillus niger as compared to standard fluconazole. Antitubercular activity of the synthesized compounds examined against Mycobacterium tuberculosis, compounds DPK4B2d1 and DPK4B2d2 shown potent activity in the comparison of standard such as Pyrazinamide, Ciprofloxacin, and Streptomycin.


Cite this article:
Deepak Kardile, Mrunal Shirsat. In vitro Antimicrobial and Antitubercular screening of newly synthesized Mercaptobenzimidazole –clubbed chalcone derivatives. Research J. Pharm. and Tech. 2021; 14(1):450-454. doi: 10.5958/0974-360X.2021.00082.2

Cite(Electronic):
Deepak Kardile, Mrunal Shirsat. In vitro Antimicrobial and Antitubercular screening of newly synthesized Mercaptobenzimidazole –clubbed chalcone derivatives. Research J. Pharm. and Tech. 2021; 14(1):450-454. doi: 10.5958/0974-360X.2021.00082.2   Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-1-82


REFERENCES:
1    Morse SS. Factors in the Emergence of Infectious Diseases. Emerging Infectious Disease.1995; 1:7-15.
2    Matsos A, Johnston IN. Chemotherapy-induced cognitive impairments: A systematic review of the animal literature. Neuroscience and Biobehavioral Reviews.  2019; 102: 382-399.
3    Saeed S, Rashid N, Jones PG, Ali M, Hussain R. Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents. European Journal of Medicinal Chemistry. 2010; 45: 1323–1331.
4    Taramian S, Mahfoozi L, Soodm M. Antibiotic Resistance Trend of Uropathogens in a Tertiary Teaching Hospital in Rasht, Iran, a Longitudinal Study. International Journal of Pharmaceutical and Phytopharmacological Research. 2019; 9(1): 98-102.
5    Randhawa MA, Bawadekji A, Al Ali M, Oueslati MH, Jamith BW. Antimicrobial effects of methanolic extract of salvia officinal is l, including MRSA and multidrug resistant Acinetobacter baumannii. International Journal of Pharmaceutical and Phytopharmacological research. 2018; 8(4): 1-5.
6    Salehi NA, Motamedifar M. Antibiotic sensitivity profile of the bacterial isolates from the blood samples of the patients in different wards of a major referral hospital, Shiraz, Iran. Pharmacophore. 2019; 10(2): 30-36.
7    Mohanty SK,  Khuntia A, Yellasubbaiah N,  Ayyanna C, Sudha BN, Harika MS. Design, synthesis of novel azo derivatives of benzimidazole as potent antibacterial and antitubercular agents. Beni-Suef University Journal of Basic and Applied Sciences. 2018; 7: 646-651.
8    Knudson SE, Kumar K, Awasthi D, Ojima I, Slayden RA.  In vitro-in vivo activity relationship of substituted benzimidazole cell division inhibitors with activity against Mycobacteria tuberculosis. Tuberculosis. 2014; 94 (3): 271-276.
9    Yoon YK, Ali MA, Wei AC, Choon TS. Synthesis and evaluation of antimycobacterial activity of new benzimidazole aminoesters. European Journal of Medicinal Chemistry. 2015; 93:614-624.
10    Yoon YK, Ali MA, Wei AC, Shirazi AN, Parang K, Choon TS. Benzimidazoles as new scaffold of sirtuin inhibitors: Green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties. European Journal of Medicinal Chemistry. 2014; 83:448-454.
11    Yajnanarayana HR, Miclmel AG, Joseph S.  X-ray crystal structure and reactions of 2-cyano-1, 3-dibenzoyl-2, 3-dihydrobenzimidazole, a novel reissert compound. Tekahedmn Letters. 1991; 32:2997-3000.
12     Padhy GK, Panda J, Behera AK. Synthesis and characterization of novel benzimidazole embedded 1,3,5-trisubstituted pyrazolines as antimicrobial agents. Journal of the Serbian Chemical Society. 2017; 82 (9): 985–993.
13    Chen GF, Dong XY. Facile and Selective Synthesis of 2-Substituted Benzimidazoles Catalyzed by FeCl3/Al2O3. European Journal of Medicinal Chemistry. 2012; 9(1): 289-293.
14    Keri RS,  Hiremathad A,  Budagumpi S, Nagaraja BM. Comprehensive Review in Current Developments of Benzimidazole – Based Medicinal Chemistry. Chem Biol Drug Des.2015; 86 (1):19-65.
15    Sridevi CH, Balaji K, Naidu A, Sudhakaran R. Synthesis of some phenylpyrazolo benzimidazolo quinoxaline derivatives as potent antihistaminic agents. European Journal of Medicinal Chemistry. 2010; 7: 234-238.
16    Ranjith PK, Rajeesh P, Haridas KR, Susanta NK, Row TN, Rishikesan R. Design and synthesis of positional isomers of 5 and 6-bromo-1-[(phenyl) sulfonyl]-2-[(4-nitrophenoxy) methyl]-1H-benzimidazoles as possible antimicrobial and antitubercular agents. Bioorg Med Chem Lett. 2013; 23:5228–5234.
17    Arora RK, Kaur N, Bansal Y, Bansal G. Novel coumarin-benzimidazole derivatives as antioxidants and safer anti-inflammatory agents. Acta Pharm Sin B. 2014; 4: 368–375.
18    Pan T, He X, Chen B, Chen H, Geng G, Luo H. Development of benzimidazole derivatives to inhibit HIV-1 replication through protectingAPOBEC3G protein. European Journal of Medicinal Chemistry. 2015; 95: 500-513.
19    Vasantha K, Basavaraja swamy G, Rai MV, Boja P, Pai VR, Shruthi N. Rapid ‘one-pot’ synthesis of a novel benzimidazole-5-carboxylate and its hydrazone derivatives as potential anti-inflammatory and antimicrobial agents. Bioorg Med Chem Lett.  2015; 25: 1420-1426.
20    Gaba M, Gaba P, Uppal D, Dhingra N, Bahia MS, Silakari O. Benzimidazole derivatives: search for GI-friendly anti-inflammatory analgesic agents. Acta Pharm Sin B.  2015; 5:337-342.
21    Wen J, Luo Y, Zhang H, Zhao H, Zhou C, Cai G. A green and convenient approach toward benzimidazole derivatives and their antimicrobial activity. Chin Chem Lett. 2016; 27: 391–394.
22    Bansal Y, Silakari O. The therapeutic journey of Benzimidazoles: a review. Bioorganic& Medicinal Chemistry.2012; 20:6208-6236.
23    Haque RA, Budagumpi S, Choo SY, Choong MK, Lokesh BE, Sudesh K. Nitrile functionalized Hg (II) - and Ag (I)-N-heterocyclic carbene complexes: synthesis, crystal structures, nuclease and DNA binding activities. Appl Organometal Chem. 2012; 26: 689-700.
24    Ansari KF, Lal C. Synthesis physicochemical properties and antimicrobial activity of some new benzimidazole derivatives. European Journal of Medicinal Chemistry.2009; 44: 4028-4033.
25    Park SJ, Lee JC, Lee K. A Facile Synthesis of 4-Hydroxycoumarin and 4-Hydroxy-2-quinolone Derivatives. Bull Korean Chemical Society. 2007; 28 (7): 1203-1205.
26    Alaqeel SI. Synthetic approaches to benzimidazole from o-phenylenediamine: A literature review. Journal of Saudi Chemical Society. 2017; 21: 229–237.
27    Boumendjel A, Bois F, Mariotte AM, Conseil G, Petro AD. Synthesis and biological activity of 4-alkoxy chalcones: potential hydrophobic modulators of P-Glycoprotein-mediated multidrug resistance. Bioorganic and Medicinal Chemistry.  1999; 7:2691–2695.
28    Parikh K, Joshi D. Antibacterial and antifungal screening of newly synthesized benzimidazole-clubbed chalcone derivatives. Medicinal Chemistry Research. 2013; 22: 3688-3697.
29    Pharmacopoeia of India, Ministry of Health Department New Delhi: Govt. of India; 1996; 2: A-88.
30    Parish T, Stroker NG. Mycobacteria Protocols: Methods in molecular Biology. Totowa NJ: Humana Press Totowa. 1998; 101: 395–422.
31    Rodriguez-Arguelles MC, Lopez-Silva EC, Sanmartin J, Pelagatti P, Zani F. Copper complexes of imidazole-2-pyrrole-2- and indol-3-carbaldehyde thiosemicarbazones: inhibitory activity against fungi and bacteria. J Inorg Biochemistry. 2005; 99: 2231–2239.
32    Emami S, Falhati M, Banifafemi A, Shafiee A. Stereoselective synthesis and antifungal activity of (Z)-Trans-3-azolyl-2-methylchromanone oxime ethers. Bioorganic and Medicinal Chemistry. 2004; 12:5881-5889.
33    Perez C, Anesini C. In vitro antimicrobial activity of Argentine folk medicinal plants against Salmonella typhii. Journal of Ethnopharmacology. 1994; 44: 41-46.
34    Kalalbandi VKA, Seetharamappa J, Katrahalli U, Bhat KG. Synthesis, crystal studies, anti-tuberculosis and cytotoxic studies of 1-[(2E)-3-phenylprop-2-enoyl]-1Hbenzimidazole derivatives. European Journal of Medicinal Chemistry. 2014; 79:194-202.
35    Vera K, Lenka Z, Waisser K, Jarmila K. Synthesis and antimycobacterial activity of 1, 2, 4-triazole 3-benzylsulfanyl derivatives. IL Farmaco. 2004; 59: 279-288.
36    Wang S, Eisenberg D. Crystal structures of a pantothenate synthetase from M. tuberculosis and its complexes with substrates and a reaction intermediate. Protein Sci.  2003; 12:1097–10108.
37    Collins LA, Franzblau SG. Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrobial agents Chemotherapy. 1997; 41:1004–1009.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available